Grant: Discovery Grants Program - Individual
McGill University
$42,000.00
Biocatalysts to generate novel aminoglycosides and hydroxylate inactivated C-H bonds
EF 2011-12
Résumé
Biocatalysts are enantio-, chemo-, and regio-selective across a wide range of reactions under mild conditions. Their use in synthesis is however limited in part by chemists' apprehension to handle enzymes. We propose to develop simple biocatalytic methods to generate novel aminoglycosides and hydroxylate inactivated C-H bonds. Aminoglycosides are clinically important broad spectrum antibiotics. Unfortunately, the emergence of resistance is increasingly restricting their use. A better understanding of resistance-causing mechanisms is critical to conquer this health threat. The synthesis of aminoglycoside derivatives is challenging because of solubility issues and of the complex protection schemes required. We have developed a novel methodology for selective N-6' acylation of aminoglycosides. This has allowed the one-pot synthesis of the first nanomolar inhibitors of resistance-causing aminoglycoside 6'-N-acetyltransferase Ii. Our next goal is to prepare aminoglycosides able to escape resistance-causing enzymes while maintaining their antibacterial activity. To this end, we propose to develop new chemoenzymatic methodologies for the regioselective derivatization of aminoglycosides. Commercial enzymes and acetyltransferases will be used. In parallel, we propose to study P450 enzymes for their impressive ability to catalyze the insertion of oxygen into non-activated C-H bonds. Very few methods exist that directly hydroxylate aliphatic C-H bonds, and most of them are of limited scope. P450s represent a promising alternative; however, a number of limitations have restricted their use. These include substrate specificity, the need for 2 or 3 cofactors, incompatibility with organic solvents, low activity and poor stability. The very promiscuous P450s 3A4 and 2D6 were selected to overcome the substrate specificity issue. We have reported that some cheap chemicals can efficiently replace the natural cofactors. and recently found conditions to use these enzymes in the presence of organic solvents. Next we propose to develop a system of substrate tagging to allow prediction of the regio- and stereo-selectivity of P450s.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
240750-2007
Name nom
Auclair, Karine
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2007
Award amount
42000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
5
Nb partie
5
Application title
Biocatalysts to generate novel aminoglycosides and hydroxylate inactivated C-H bonds
Keyword
NSERC
Application summary
Biocatalysts are enantio-, chemo-, and regio-selective across a wide range of reactions under mild conditions. Their use in synthesis is however limited in part by chemists' apprehension to handle enzymes. We propose to develop simple biocatalytic methods to generate novel aminoglycosides and hydroxylate inactivated C-H bonds. Aminoglycosides are clinically important broad spectrum antibiotics. Unfortunately, the emergence of resistance is increasingly restricting their use. A better understanding of resistance-causing mechanisms is critical to conquer this health threat. The synthesis of aminoglycoside derivatives is challenging because of solubility issues and of the complex protection schemes required. We have developed a novel methodology for selective N-6' acylation of aminoglycosides. This has allowed the one-pot synthesis of the first nanomolar inhibitors of resistance-causing aminoglycoside 6'-N-acetyltransferase Ii. Our next goal is to prepare aminoglycosides able to escape resistance-causing enzymes while maintaining their antibacterial activity. To this end, we propose to develop new chemoenzymatic methodologies for the regioselective derivatization of aminoglycosides. Commercial enzymes and acetyltransferases will be used. In parallel, we propose to study P450 enzymes for their impressive ability to catalyze the insertion of oxygen into non-activated C-H bonds. Very few methods exist that directly hydroxylate aliphatic C-H bonds, and most of them are of limited scope. P450s represent a promising alternative; however, a number of limitations have restricted their use. These include substrate specificity, the need for 2 or 3 cofactors, incompatibility with organic solvents, low activity and poor stability. The very promiscuous P450s 3A4 and 2D6 were selected to overcome the substrate specificity issue. We have reported that some cheap chemicals can efficiently replace the natural cofactors. and recently found conditions to use these enzymes in the presence of organic solvents. Next we propose to develop a system of substrate tagging to allow prediction of the regio- and stereo-selectivity of P450s.